Similar articles

• [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].

  Grigor'iants RA, Lupanov VP, Samoĭlenko LE, Lobova NM. Grigor'iants RA, et al. Ter Arkh. 1984;56(4):67-70. Ter Arkh. 1984. PMID: 6427964 Clinical Trial. Russian. No abstract available.
• [Hemodynamic effects of microencapsulated trinitrine].

  Groussin P. Groussin P. Nouv Presse Med. 1975 Dec 20;4(44):3139-40. Nouv Presse Med. 1975. PMID: 815884 French. No abstract available.
• Transmucosal and transdermal nitroglycerin delivery systems for prevention of chronic stable angina pectoris.

  Khurmi NS, O'Hara MJ, Bowles MJ, Whittington JR, Lahiri A, Raftery EB. Khurmi NS, et al. Br J Clin Pract. 1986 May;40(5):187-91. Br J Clin Pract. 1986. PMID: 3092852 Clinical Trial. No abstract available.
• [Angina pectoris].

  Donat K. Donat K. Internist (Berl). 1971 Feb;12(2):33-9. Internist (Berl). 1971. PMID: 4396168 Review. German. No abstract available.
• Measurement of the quality of life in angina.

  Bulpitt CJ, Fletcher AE. Bulpitt CJ, et al. J Hypertens Suppl. 1987 Feb;5(1):S41-5. J Hypertens Suppl. 1987. PMID: 3106601 Review. No abstract available.